Matthew R. Henn, Officer of Seres Therapeutics MCRB, has filed 0 purchases and 12 sales on the open market. Over the past 12 months that comes to a net sale of $23.1K. The latest trade was on 05/18.

MH

MH

Matthew R. Henn

SEE REMARKS

Company

Seres Therapeutics MCRB

First filing

23/02/07

Trades

58 trades

Buys / sales

0 / 12

12-month net buying

−$23.1K

Last trade

05/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	05/18	05/19	77 sh	$7.53	$579.81	−1.0%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	02/15	02/18	89 sh	$8.47	$753.83	−1.1%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	25/11/15	25/11/18	1,257 sh	$17.30	$21,746.1	−14.3%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	25/08/18	25/08/19	73 sh	$16.65	$1,215.45	−1.6%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	25/05/16	25/05/19	77 sh	$7.28	$560.56	−1.7%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	25/02/18	25/02/19	3,953 sh	$0.81	$3,201.93	−4.5%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	24/11/18	24/11/19	927 sh	$0.54	$500.58	−1.2%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	24/10/28	24/10/29	3,984 sh	$0.69	$2,748.96	−5.0%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	24/08/16	24/08/19	923 sh	$0.84	$775.32	−1.4%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	24/05/15	24/05/17	891 sh	$0.94	$837.54	−1.3%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	24/02/16	24/02/16	4,170 sh	$1.08	$4,503.6	−6.2%
Seres TherapeuticsMCRB	Open-market sale10b5-1 plan	23/10/30	23/10/31	3,886 sh	$1.35	$5,246.1	−6.5%